Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Austin I Kim, M.D.

Concepts (71)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lymphoma, Large B-Cell, Diffuse4202414050.400 Why?
Hematopoietic Stem Cell Transplantation8202356720.400 Why?
Hodgkin Disease3202213780.320 Why?
Lymphoma, Mantle-Cell220232370.320 Why?
Transplantation, Autologous7202321150.230 Why?
Lymphoma, T-Cell, Peripheral120231250.190 Why?
Vincristine1202410360.190 Why?
Anthracyclines120232840.190 Why?
Histiocytes12021980.180 Why?
Antibiotics, Antineoplastic120236780.170 Why?
Neurotoxicity Syndromes120233010.160 Why?
Lymphoma, Follicular120234570.160 Why?
Prednisone1202415630.160 Why?
Cyclophosphamide1202422200.150 Why?
Tumor Escape120213700.150 Why?
Doxorubicin1202422240.140 Why?
Cardiovascular Agents120238400.140 Why?
Antineoplastic Combined Chemotherapy Protocols52024117420.130 Why?
Benzamides1202113700.130 Why?
Pyrazines1202112010.130 Why?
Lymphoma1202319010.110 Why?
Lymphoma, B-Cell120209400.110 Why?
Neoplasm, Residual3202310080.110 Why?
Immunoconjugates120209530.110 Why?
Sulfonamides1202119780.100 Why?
Saccharomyces cerevisiae1202226880.090 Why?
Stem Cell Transplantation3202316000.090 Why?
Heart Diseases1202327810.090 Why?
Leukemia, Lymphocytic, Chronic, B-Cell1202116400.090 Why?
T-Lymphocytes32023101940.090 Why?
Neoplasm Recurrence, Local5202392800.070 Why?
Antibodies, Monoclonal2202391770.070 Why?
Leukocytes, Mononuclear2202318440.060 Why?
Disease-Free Survival2202368150.050 Why?
Antineoplastic Agents12023136420.040 Why?
Antigens, CD19120234240.040 Why?
Double-Blind Method22024123410.040 Why?
Retreatment120205980.040 Why?
Cytarabine120206980.040 Why?
Humans1520247615720.030 Why?
Product Surveillance, Postmarketing120204520.030 Why?
Central Nervous System1202313360.030 Why?
Remission Induction1202123970.030 Why?
Adult720242212030.030 Why?
Receptors, Antigen, T-Cell1202325470.030 Why?
Immunotherapy, Adoptive1202314690.030 Why?
Drug Administration Schedule1202148530.030 Why?
Tissue Donors1202223320.030 Why?
Salvage Therapy1201912640.030 Why?
Aged520241693100.030 Why?
Treatment Outcome32024646840.020 Why?
Prognosis22022296290.020 Why?
Middle Aged520242209200.020 Why?
Ventricular Function, Left1202338790.020 Why?
Tumor Microenvironment1202338770.020 Why?
Disease Management1202025080.020 Why?
Stroke Volume1202354960.020 Why?
Retrospective Studies32023806460.020 Why?
Boston1202193260.020 Why?
Recurrence1202084660.020 Why?
CD8-Positive T-Lymphocytes1202145800.020 Why?
Immunotherapy1202346520.020 Why?
Male520243608420.020 Why?
Female520243926860.020 Why?
Drug Resistance, Neoplasm1202053050.020 Why?
Follow-Up Studies12023391070.010 Why?
Time Factors12021399700.010 Why?
Heart Failure12023116700.010 Why?
Aged, 80 and over12020589860.010 Why?
Young Adult12020592550.010 Why?
Adolescent12020883240.010 Why?
Kim's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (71)
Explore
_
Co-Authors (58)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.